SPDR S&P Biotech Company Profile (NYSEARCA:XBI)

Analyst Ratings

Consensus Ratings for SPDR S&P Biotech (NYSEARCA:XBI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SPDR S&P Biotech (NYSEARCA:XBI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for SPDR S&P Biotech (NYSEARCA:XBI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/19/2015quarterly$0.440.69%6/19/20156/23/20156/29/2015Tweet This Announcement  Share This Announcement on StockTwits
3/20/2015quarterly$0.250.42%3/20/20153/24/20153/30/2015Tweet This Announcement  Share This Announcement on StockTwits
12/19/2014quarterly$0.491.03%12/19/201412/23/201412/30/2014Tweet This Announcement  Share This Announcement on StockTwits
9/19/2014quarterly$0.561.42%9/19/20149/23/20149/29/2014Tweet This Announcement  Share This Announcement on StockTwits
6/20/2014quarterly$0.621.61%6/20/20146/24/20146/30/2014Tweet This Announcement  Share This Announcement on StockTwits
3/21/2014quarterly$0.330.87%3/21/20143/25/20143/31/2014Tweet This Announcement  Share This Announcement on StockTwits
12/20/2013quarterly$0.040.12%12/20/201312/24/201312/31/2013Tweet This Announcement  Share This Announcement on StockTwits
9/20/2013quarterly$0.090.27%9/20/20139/24/20139/30/2013Tweet This Announcement  Share This Announcement on StockTwits
3/15/2013quarterly$0.040.18%3/15/20133/19/20133/25/2013Tweet This Announcement  Share This Announcement on StockTwits
12/21/2012quarterly$0.200.89%12/21/201212/26/20121/4/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for SPDR S&P Biotech (NYSEARCA:XBI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for SPDR S&P Biotech (NYSEARCA:XBI)
DateHeadline
07/28/16 07:50 PMFOMC Keeps the Door Open for a Live Meeting in September - Market Realist
07/28/16 12:58 PMCelgene Set to Squeeze Short Sellers (CELG, IBB) -
07/28/16 10:43 AMWednesday's ETF Movers: XBI, FXN
07/27/16 07:50 PMBLUE Crosses Above Key Moving Average Level - Nasdaq
07/27/16 07:50 PMNotable ETF Inflow Detected - XBI, IONS, TSRO, BMRN - NASDAQ ... - Nasdaq
07/27/16 10:34 AMNotable ETF Inflow Detected - XBI, IONS, TSRO, BMRN
07/25/16 04:49 AM4 Things To Watch When Gilead Sciences Reports On Monday - Investing.com
07/25/16 04:49 AM5 Reasons Biotech Stocks Are Smart Investments - Madison.com
07/25/16 04:00 AMThis Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles -
07/24/16 06:48 PMWill the Recent Biotech Boom Run out of Steam?
07/24/16 04:46 AMBullish Two Hundred Day Moving Average Cross - RDUS - Nasdaq
07/22/16 07:07 PM3 Ways to Invest in Biotech
07/22/16 10:16 AM3 Ways to Invest in Biotech - Investing News Network (press release) (registration) (blog)
07/21/16 10:10 AMWill Orenitram Lose Market Share to Uptravi in 2016?
07/21/16 10:10 AMXBI, JPXN: Big ETF Outflows
07/21/16 10:10 AMBiotech ETFs Rally as Earnings Boost Optimism
07/21/16 10:10 AMSPDR S&P Biotech Breaks Above 200-Day Moving Average - Bullish for XBI
07/20/16 08:28 PMBiotech ETFs Rally as Earnings Boost Optimism - ETF Trends
07/20/16 08:28 PMWhy I Bought Shares of Regeneron Pharmaceuticals Inc. Last Week - Motley Fool
07/20/16 08:28 PMSPDR S&P Biotech Breaks Above 200-Day Moving Average - Bullish for XBI - Nasdaq
07/20/16 10:13 AMWednesday's ETF Movers: XBI, GDXJ
07/19/16 07:32 PMEarnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why - Madison.com
07/19/16 08:17 AMRegistered $-61.86M Redemptions After -3.06% AUM Decrease - Consumer Eagle
07/19/16 08:17 AMBrainstorm Cell Therapeutics' stock jumps after ALS drug trial results - MarketWatch
07/19/16 08:17 AMCould the Rise in Retail Sales and CPI Impact Portfolios? - Market Realist
07/16/16 10:31 AMWhat Is Ligand Pharmaceuticals's Expected Revenue Growth in 2016? - Market Realist
07/14/16 07:36 PMLigand Pharmaceuticals's Performance Based on EV-to-EBITDA - Market Realist
07/13/16 08:00 AMBiotech ETFs: Will the Once Hot Group Rebound? -
07/12/16 07:35 PMSPDR S&P Biotech ETF Experiences Big Inflow - Nasdaq
07/08/16 10:09 AMJuno Therapeutics Plunges 30% After 2 Patient Deaths From Lead Cancer Drug
07/07/16 07:25 PMStrong ISM Non-Manufacturing PMI Overshadows Services PMI - Market Realist
07/07/16 07:25 PMJuno Therapeutics Plunges 30% After 2 Patient Deaths From Lead Cancer Drug - Benzinga
07/06/16 04:46 AMAfter a 31% Decline, Can Shares of Ophthotech Inc. Bounce Back Later This Year? - Motley Fool
07/02/16 06:43 PMHow Could the Novartis-Xencor Alliance Benefit Novartis? - Market Realist
07/02/16 06:43 PMNoteworthy ETF Outflows: XBI, IONS, ALKS, ICPT - Nasdaq
07/02/16 06:43 PMSPDR S&P Biotech (ETF) Just Recorded A Sigfniciant Bearish Options Activity - Engelwood Daily
06/30/16 07:33 PMTesaro (TSRO) Skyrockets on Phase 3 Ovarian Cancer Data - Economic Calendar
06/30/16 07:33 PMUS Inflation Numbers Are Decent, Brexit Clouds Future Outlook - Market Realist
06/30/16 05:33 PMBiotechs Building Base?...Or Bursting Bubble? -
06/30/16 02:54 PMThe Novartis-Xencor Collaboration Agreement: The Details -
06/30/16 10:00 AMUS Inflation Numbers Are Decent, Brexit Clouds Future Outlook
06/29/16 07:15 PMMarkets Reversed on June 28: Is the Rebound Sustainable?
06/29/16 10:00 AMTuesday's ETF Movers: XBI, RHS
06/28/16 07:18 PMRegulus Therapeutics' stock set to fall after FDA places hepatitis C treatment on hold - MarketWatch
06/28/16 07:18 PMSubdued Service Sector Growth Puts Further Pressure on Markets - Market Realist
06/26/16 06:08 PMLook back at pharma news to June 24 - The Pharma Letter (registration)
06/24/16 07:19 PMBrexit means little for biotech stocks, analyst says - MarketWatch
06/23/16 08:08 PMHealthcare and Biotech Gain in an Otherwise Negative Market
06/22/16 07:18 PMTraders Get It Right (Sort Of) With Leveraged Biotech ETFs - Benzinga
06/22/16 01:07 PMTraders Get It Right (Sort Of) With Leveraged Biotech ETFs -

Social

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: Exchange Traded Fund
  • Sub-Industry: N/A
  • Exchange: NYSEARCA
  • Symbol: XBI
  • CUSIP:
Key Metrics:
  • Previous Close: $61.32
  • 50 Day Moving Average: $55.89
  • 200 Day Moving Average: $53.56
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $N/A EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: